139 related articles for article (PubMed ID: 38141896)
41. Bronchiolitis obliterans syndrome due to donor-specific HLA-antibodies.
Kauke T; Kneidinger N; Martin B; Dick A; Schneider C; Schramm R; Meimarakis G; Preissler G; Eickelberg O; von Dossow V; Behr J; Hatz R; Neurohr C; Winter H
Tissue Antigens; 2015 Sep; 86(3):178-85. PubMed ID: 26204790
[TBL] [Abstract][Full Text] [Related]
42. Decline in Club Cell Secretory Proteins, Exosomes Induction and Immune Responses to Lung Self-antigens, Kα1 Tubulin and Collagen V, Leading to Chronic Rejection After Human Lung Transplantation.
Itabashi Y; Ravichandran R; Bansal S; Bharat A; Hachem R; Bremner R; Smith M; Mohanakumar T
Transplantation; 2021 Jun; 105(6):1337-1346. PubMed ID: 32890135
[TBL] [Abstract][Full Text] [Related]
43. HLA-C mismatching improves outcomes following lung transplantation.
Hiho SJ; Levvey BJ; Diviney MB; Brooks AG; Holdsworth R; Snell GI; Westall GP; Sullivan LC
HLA; 2024 Jun; 103(6):e15544. PubMed ID: 38924641
[TBL] [Abstract][Full Text] [Related]
44. Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD).
Keller M; Bush E; Diamond JM; Shah P; Matthew J; Brown AW; Sun J; Timofte I; Kong H; Tunc I; Luikart H; Iacono A; Nathan SD; Khush KK; Orens J; Jang M; Agbor-Enoh S
J Heart Lung Transplant; 2021 Jun; 40(6):488-493. PubMed ID: 33814284
[TBL] [Abstract][Full Text] [Related]
45. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
46. Pretransplant angiotensin II type 1-receptor antibodies are a risk factor for earlier detection of de novo HLA donor-specific antibodies.
Cuevas E; Arreola-Guerra JM; Hernández-Méndez EA; Salcedo I; Castelán N; Uribe-Uribe NO; Vilatobá M; Contreras-Saldívar AG; Sánchez-Cedillo AI; Ramírez JB; de Rungs D; Granados J; Morales-Buenrostro LE; Alberú J
Nephrol Dial Transplant; 2016 Oct; 31(10):1738-45. PubMed ID: 27220757
[TBL] [Abstract][Full Text] [Related]
47. Anti-HLA antibodies and kidney allograft outcomes in recipients with donor bone marrow cell infusion.
Solgi G; Pourmand G; Mehrsai A; Taherimahmoudi M; Nicknam MH; Ebrahimi Rad MR; Seraji A; Asadpoor A; Ansaripor B; Nikbin B; Amirzargar A
Iran J Immunol; 2010 Mar; 7(1):18-29. PubMed ID: 20371916
[TBL] [Abstract][Full Text] [Related]
48. Bronchoalveolar lavage cytokine-based risk stratification of minimal acute rejection in clinically stable lung transplant recipients.
Levy L; Huszti E; Ahmed M; Ghany R; Hunter S; Moshkelgosha S; Zhang CYK; Boonstra K; Klement W; Tikkanen J; Singer LG; Keshavjee S; Juvet S; Martinu T
J Heart Lung Transplant; 2021 Dec; 40(12):1540-1549. PubMed ID: 34215500
[TBL] [Abstract][Full Text] [Related]
49. Acute antibody-mediated rejection after lung transplantation.
Witt CA; Gaut JP; Yusen RD; Byers DE; Iuppa JA; Bennett Bain K; Alexander Patterson G; Mohanakumar T; Trulock EP; Hachem RR
J Heart Lung Transplant; 2013 Oct; 32(10):1034-40. PubMed ID: 23953920
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of current strategies for surveillance and management of donor-specific antibodies: Single-center study.
Sullivan D; Ahn C; Gao A; Lacelle C; Torres F; Bollineni S; Banga A; Mullins J; Mohanka M; Ring S; Wait M; Peltz M; Duddupudi P; Surapaneni D; Kaza V
Clin Transplant; 2018 Jul; 32(7):e13285. PubMed ID: 29774598
[TBL] [Abstract][Full Text] [Related]
51. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.
Rebellato LM; Ozawa M; Verbanac KM; Catrou P; Haisch CE; Terasaki PI
Clin Transpl; 2006; ():241-53. PubMed ID: 18365382
[TBL] [Abstract][Full Text] [Related]
52. Significance of HLA-matching and anti-HLA antibodies in heart transplant patients receiving induction therapy?
Gavroy B; Timmermans T; Van Caenegem O; Mastrobuoni S; Jacquet L; Latinne D; Poncelet AJ
Transpl Immunol; 2022 Dec; 75():101706. PubMed ID: 36113729
[TBL] [Abstract][Full Text] [Related]
53. Donor human leukocyte antigen-G single nucleotide polymorphisms are associated with post-lung transplant mortality.
Lazarte J; Ma J; Martinu T; Levy L; Klement W; White M; Pelling J; Guan Z; Azad S; Tikkanen J; Rao V; Tomlinson G; Delgado D; Keshavjee S; Juvet SC
Eur Respir J; 2019 Aug; 54(2):. PubMed ID: 31164432
[TBL] [Abstract][Full Text] [Related]
54. Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA.
Solgi G; Furst D; Mytilineos J; Pourmand G; Amirzargar AA
Transpl Immunol; 2012 Mar; 26(2-3):81-7. PubMed ID: 22182633
[TBL] [Abstract][Full Text] [Related]
55. Detection and clinical impact of human leukocyte antigen antibodies in lung transplantation: A systematic review and meta-analysis.
Courtwright A; Diamond JM; Wood I; Guleria I; Milford E; El-Chemaly S; Goldberg HJ
HLA; 2018 Feb; 91(2):102-111. PubMed ID: 29178607
[TBL] [Abstract][Full Text] [Related]
56. Both donor specific and non-donor specific HLA antibodies reduced in recipients post simultaneous liver/kidney transplant.
Zhang X; Wisel SA; Haas M; Kim I; Jordan S
Transpl Immunol; 2022 Dec; 75():101744. PubMed ID: 36372143
[TBL] [Abstract][Full Text] [Related]
57. Risk factors, histopathological features, and graft outcome of transplant glomerulopathy in the absence of donor-specific HLA antibodies.
Senev A; Van Loon E; Lerut E; Callemeyn J; Coemans M; Van Sandt V; Kuypers D; Emonds MP; Naesens M
Kidney Int; 2021 Aug; 100(2):401-414. PubMed ID: 33675843
[TBL] [Abstract][Full Text] [Related]
58. Pre-transplant HLA Antibodies and Delayed Graft Function in the Current Era of Kidney Transplantation.
Morath C; Döhler B; Kälble F; Pego da Silva L; Echterdiek F; Schwenger V; Živčić-Ćosić S; Katalinić N; Kuypers D; Benöhr P; Haubitz M; Ziemann M; Nitschke M; Emmerich F; Pisarski P; Karakizlis H; Weimer R; Ruhenstroth A; Scherer S; Tran TH; Mehrabi A; Zeier M; Süsal C
Front Immunol; 2020; 11():1886. PubMed ID: 32983110
[TBL] [Abstract][Full Text] [Related]
59. Prevalence of pre-transplant anti-HLA antibodies and their impact on outcomes in lung transplant recipients.
Park JE; Kim CY; Park MS; Song JH; Kim YS; Lee JG; Paik HC; Kim SY
BMC Pulm Med; 2018 Mar; 18(1):45. PubMed ID: 29529999
[TBL] [Abstract][Full Text] [Related]
60. Pseudomonas aeruginosa and acute rejection independently increase the risk of donor-specific antibodies after lung transplantation.
Kulkarni HS; Tsui K; Sunder S; Ganninger A; Tague LK; Witt CA; Byers DE; Trulock EP; Nava R; Puri V; Kreisel D; Mohanakumar T; Gelman AE; Hachem RR
Am J Transplant; 2020 Apr; 20(4):1028-1038. PubMed ID: 31677358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
